Bill Status of HB 3519   99th General Assembly

Short Description:  PHARMACY PRACTICE-BIOSIMILARS

House Sponsors
Rep. David Harris-Lou Lang-Patricia R. Bellock

Last Action  View All Actions

DateChamber Action
  1/10/2017HouseSession Sine Die

Statutes Amended In Order of Appearance
225 ILCS 85/19.5 new

Synopsis As Introduced
Amends the Pharmacy Practice Act. Provides that a pharmacist may substitute a prescription biosimilar product for a prescribed biological product under certain circumstances. Provides that the Board shall adopt rules for compliance with these provisions. Effective immediately.

House Committee Amendment No. 3
Replaces everything after the enacting clause. Amends the Pharmacy Practice Act. Provides that a pharmacist may substitute a biological product only if: the substituted product has been determined by the United States Food and Drug Administration to be interchangeable; the prescribing physician does not designate that substitution is prohibited; the pharmacy informs the patient of the substitution; and the selected biological product that will be used as the substitution has a unit price less than the biological product specified in the prescription or, if the unit price of the selected biological product is higher than the unit price of the prescribed biological product, the patient is informed and has agreed to accept the selected biological product. Requires that, no later than 5 days after the time of dispensing of a biological product, the dispensing pharmacist or the pharmacist's designee shall communicate to the prescriber the specific product provided to the patient; specifies exceptions. Requires the State Board of Pharmacy to maintain a link on the Department of Financial and Professional Regulation's Internet website to the current list of all biological products determined by the United States Food and Drug Administration to be interchangeable with a specific biological product. Effective July 1, 2016.

Actions 
DateChamber Action
  2/26/2015HouseFiled with the Clerk by Rep. David Harris
  2/26/2015HouseFirst Reading
  2/26/2015HouseReferred to Rules Committee
  3/10/2015HouseAssigned to Health Care Licenses Committee
  3/10/2015HouseAdded Chief Co-Sponsor Rep. Lou Lang
  3/11/2015HouseAdded Chief Co-Sponsor Rep. Patricia R. Bellock
  3/11/2015HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. David Harris
  3/11/2015HouseHouse Committee Amendment No. 1 Referred to Rules Committee
  3/13/2015HouseHouse Committee Amendment No. 2 Filed with Clerk by Rep. David Harris
  3/13/2015HouseHouse Committee Amendment No. 2 Referred to Rules Committee
  3/16/2015HouseHouse Committee Amendment No. 1 Rules Refers to Health Care Licenses Committee
  3/17/2015HouseHouse Committee Amendment No. 2 Rules Refers to Health Care Licenses Committee
  3/23/2015HouseHouse Committee Amendment No. 3 Filed with Clerk by Rep. David Harris
  3/23/2015HouseHouse Committee Amendment No. 3 Referred to Rules Committee
  3/24/2015HouseHouse Committee Amendment No. 3 Rules Refers to Health Care Licenses Committee
  3/25/2015HouseHouse Committee Amendment No. 3 Adopted in Health Care Licenses Committee; 011-000-000
  3/25/2015HouseDo Pass as Amended / Short Debate Health Care Licenses Committee; 011-000-000
  3/25/2015HouseHouse Committee Amendment No. 1 Tabled Pursuant to Rule 40
  3/25/2015HouseHouse Committee Amendment No. 2 Tabled Pursuant to Rule 40
  3/25/2015HousePlaced on Calendar 2nd Reading - Short Debate
  4/22/2015HouseSecond Reading - Short Debate
  4/22/2015HouseHeld on Calendar Order of Second Reading - Short Debate
  4/24/2015HouseRule 19(a) / Re-referred to Rules Committee
  1/10/2017HouseSession Sine Die

Back To Top